PC

Paul Conley

Founder of General Inception

Palo Alto, California

Overview 

Paul Conley is a seasoned professional with a strong track record in deep-tech company formation and venture capital, currently serving as the Founder/CEO of General Inception and as a Venture Partner at Vertical Venture Partners. Notable highlights of his career include his role as Managing Director for Venture Studio Operations at Paladin Capital Group and his involvement as an investor and board member in companies like 10X Genomics and Menlo Micro.

Work Experience 

  • Founder / CEO

    2020 - Current

    A venture igniter company dedicated to technical founders who need ignition capital ($50k - 1.5M), hands-on technology development and access to customers on the way to preparing for their first financing round.

General Inception is an institutional co-founder for science-based companies.

  • Venture Partner

    2015

    Early stage investor in B2B start-ups who are solving vertical industry problems that are not addressed by general purpose products. VVP invests at the intersection of new technologies and industry specific solutions, including (but not limited to) healthcare, education, insurance, aero/defense, retail, travel, real-estate, transportation, energy, etc.

  • Managing Director for Venture Studio Operations

    2007

    Paladin is a multi-stage private equity firm with a concentration on expansion and growth stage investments in companies whose products or services address the security and resilience of US critical infrastructure.

  • Board Member

    2022

  • fmr Board Member (NASDAQ: TXG)

    2012

  • Investor (co-founder)

    2018

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

Raised $119,145,000.00 from U.S. Department of Defense and National Institute on Drug Abuse (NIDA).

  • Board Member

    2015

Menlo Micro is the developer of the Ideal Switch, an electromechanical switch technology used to switch AC/DC and RF.

Raised $227,500,000.00 from Piva Capital, Paladin Capital Group, PeopleFund, Lakewood & Company, Adage Capital Management, Future Shape, Fidelity, DBL Partners and Vertical Venture Partners.

  • Board Observer

    2017

  • fmr Board Member (NASDAQ: TWST)

    2013

Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.

Raised $553,110,714.00 from Capital World Investors.

  • Investor (NASDAQ: CMPS)

    2020

Education 

Articles About Paul

Relevant Websites